36 related articles for article (PubMed ID: 38455982)
21. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
Lim J; Lomax AJ; McNeil C; Harrisberg B
Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
[TBL] [Abstract][Full Text] [Related]
22. Trametinib: a MEK inhibitor for management of metastatic melanoma.
Lugowska I; Koseła-Paterczyk H; Kozak K; Rutkowski P
Onco Targets Ther; 2015; 8():2251-9. PubMed ID: 26347206
[TBL] [Abstract][Full Text] [Related]
23. Trametinib (MEKINIST°) Metastatic or inoperable BRAF V600-positive melanoma: a few extra months of life.
Prescrire Int; 2016 Dec; 25(177):285-288. PubMed ID: 30758923
[TBL] [Abstract][Full Text] [Related]
24. New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy.
Luke JJ; Ott PA
Drug Healthc Patient Saf; 2014; 6():77-88. PubMed ID: 25018652
[TBL] [Abstract][Full Text] [Related]
25. New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease.
Abu El-Asrar AM; Van Damme J; Struyf S; Opdenakker G
Front Med (Lausanne); 2021; 8():705796. PubMed ID: 34869409
[TBL] [Abstract][Full Text] [Related]
26. VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report.
Gunaratnam C; Muzicenco O; Sivagurunathan P; Franzco MH
J Surg Case Rep; 2024 Mar; 2024(3):rjae104. PubMed ID: 38455982
[TBL] [Abstract][Full Text] [Related]
27. [Vogt-Koyanagi-Harada disease].
Bonnet C; Daudin JB; Monnet D; Brézin A
J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
[TBL] [Abstract][Full Text] [Related]
28. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
[TBL] [Abstract][Full Text] [Related]
30. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
31. Truth or dare: switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma - A case report and review of the literature.
De Ryck L; Delanghe S; Jacobs C; Fadaei S; Brochez L; Saerens M
Acta Clin Belg; 2023 Jun; 78(3):215-222. PubMed ID: 35996969
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
